Use access key #2 to skip to page content.

JimVanMeerten's rating is 64.66.

  • Score: 2352.62 (92nd percentile)
  • Accuracy: 32.10% (5th percentile)

A player's rating indicates his percentile rank in CAPS. JimVanMeerten is outperforming 64.66% of all CAPS players. A player's score is the total percentage return of all his picks subtracting out the S&P. A player's accuracy is how often that player has made correct predictions.

To calculate a player's rating, we take 2/3 of his score percentile and 1/3 of his accuracy percentile. For further information, read the Player Ratings section of the Help page.

Average Pick Score is a player's total score divided by the total number of picks (active and closed). It represents the player's average return after subtracting out the market's performance.

Average Pick Rating is the average stock rating of a player's total picks. Underperform picks are flip-flopped, so a underperform call on a one-star stock is treated like an outperform call on a five-star stock. This rating reflects how closely your picks are aligned with CAPS ratings.

Ratings last updated at 5:46 PM 7/1/2015.

JimVanMeerten (64.66)

JimVanMeerten is beating the market today

Player Rating CAPS Rating

64.66

Rank: 26584 out of 75214
Score: 2,352.62 (+37.43)
Accuracy: 32.10%
Average Pick Score: +2.46
Average Pick Rating:
All-Time Best: TCX +1225.39
All-Time Worst: GCI -59.46

Score Comparison vs. JimVanMeerten

Player History

How are these stats calculated?

JimVanMeerten's Latest Blog Post

Recs

1

Alder Biopharmaceuticals - All Time High

June 30, 2015 – Comments (0) | RELATED TICKERS: ALDR

The Chart of the Day belongs to Alder Biopharmaceuticals (ALDR).  I found the bio medical stock when I used Barchart to sort the All Time High list for the stocks with the highest technical buy signals then used the Flipchart feature to review the charts,  Since the Trend Spotter signaled a buy on 5/6 the stock gained 88.16%.

Alder Biopharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It discovers, develops and seeks to commercialize therapeutic antibodies. It is developing monoclonal antibodies comprising ALD403, for the prevention of migraine; and Clazakizumab, in the treatment of rheumatoid arthritis and psoriatic arthritis. Alder Biopharmaceuticals Inc. is headquartered in Bothell, Washington.


The status of Barchart's Opinion trading systems are listed below.  Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates.  The indicator numbers shown below therefore may not match what you see live on the Barchart.com web site when you read this report


Barchart technical indicators:

100% Barchart technical buy signalsTrend Spotter buy signalAbove its 20, 50 and 100 day moving averages10 new highs and up 22.44% in the last monthRelative Strength Index 68.80%Barchart computes a technical support level at 42.61Recently traded at 52.85 with a 50 day moving average of 38.77  [more]

JimVanMeerten's Stock Picks

Results 1 - 63 of 63  

picks per page. CHANGE

Top
Pick
Start
Date
TickerCAPS RatingCallTime FrameStart PriceToday (Change)Stock
Gain
Index
Gain
ScorePitch
04/22/15 SLB Outperform NS $91.62 $84.30
( 0%)
-7.99%-1.12%-6.87
04/22/15 COG Outperform NS $33.03 $31.00
( 0%)
-6.15%-1.12%-5.02
04/22/15 HZNP Outperform NS $31.11 $34.58
( 0%)
+11.15%-1.13%+12.29
04/22/15 NOAH Outperform NS $31.85 $28.52
( 0%)
-10.46%-1.13%-9.32
04/06/15 HXL Outperform NS $51.46 $50.21
( 0%)
-2.42%+1.07%-3.50
04/06/15 PKI Outperform NS $51.06 $52.49
( 0%)
+2.80%+1.07%+1.73
03/19/15 WBA Outperform NS $86.87 $85.77
( 0%)
-1.27%-0.82%-0.45
03/19/15 ABC Outperform NS $111.55 $107.71
( 0%)
-3.44%-0.82%-2.63
03/19/15 ROL Outperform NS $24.29 $27.68
( 0%)
+13.95%-0.82%+14.77
03/19/15 MMS Outperform NS $65.15 $66.14
( 0%)
+1.51%-0.82%+2.33
03/19/15 ANAC Outperform NS $55.83 $79.79
( 0%)
+42.92%-0.80%+43.72
03/19/15 ALJ Outperform NS $14.86 $18.82
( 0%)
+26.65%-0.86%+27.52
03/19/15 PNFP Outperform NS $43.55 $55.04
( 0%)
+26.38%-0.86%+27.24
03/19/15 SFNC Outperform NS $43.87 $47.27
( 0%)
+7.74%-0.86%+8.61
03/19/15 CGNX Outperform NS $49.44 $47.51
( 0%)
-3.91%-0.81%-3.09
03/19/15 CAL Outperform NS $31.69 $32.47
( 0%)
+2.48%-0.81%+3.29
03/19/15 NPTN Outperform NS $6.14 $9.21
( 0%)
+50.00%-0.82%+50.82
03/19/15 SPWH Outperform NS $8.01 $11.86
( 0%)
+48.06%-0.85%+48.91
03/19/15 COWN Outperform NS $5.45 $6.44
( 0%)
+18.17%-0.85%+19.01
03/19/15 AGRO Outperform NS $9.94 $9.20
( 0%)
-7.44%-0.85%-6.60
03/19/15 CBNJ Outperform NS $9.29 $9.47
( 0%)
+1.92%-0.80%+2.71
03/19/15 CWST Outperform NS $5.00 $5.59
( 0%)
+11.80%-0.80%+12.60
03/19/15 SWKS Outperform NS $99.20 $103.90
( 0%)
+4.75%-0.81%+5.56
03/19/15 FL Outperform NS $61.74 $67.97
( 0%)
+10.10%-0.81%+10.91
03/19/15 PNK Outperform NS $35.21 $37.53
( 0%)
+6.59%-0.81%+7.40
02/09/15 DATA Outperform NS $94.70 $116.98
( 0%)
+23.53%+1.37%+22.16
02/09/15 CTO Outperform NS $56.71 $58.25
( 0%)
+2.72%+1.37%+1.35
02/09/15 DST Outperform NS $103.23 $126.85
( 0%)
+22.88%+1.37%+21.51
02/09/15 DY Outperform NS $35.95 $63.48
( 0%)
+76.58%+1.37%+75.21
02/09/15 STNR Outperform NS $45.50 $54.07
( 0%)
+18.84%+1.37%+17.47
02/09/15 RE Outperform NS $179.56 $185.80
( 0%)
+3.48%+1.37%+2.11
02/09/15 DOX Outperform NS $49.27 $55.60
( 0%)
+12.84%+1.37%+11.47
02/09/15 ASH Outperform NS $124.51 $122.66
( 0%)
-1.49%+1.37%-2.85
02/09/15 FISV Outperform NS $76.66 $84.11
( 0%)
+9.72%+1.37%+8.35
01/26/15 Q Outperform NS $61.88 $72.97
( 0%)
+17.92%+1.31%+16.61
01/26/15 UHAL Outperform NS $291.24 $331.27
( 0%)
+13.75%+1.31%+12.43
01/26/15 ORRF Outperform NS $17.30 $16.16
( 0%)
-6.59%+1.31%-7.90
01/26/15 BX Outperform NS $34.51 $40.92
( 0%)
+18.58%+1.27%+17.31
01/26/15 AGN Outperform NS $282.04 $298.98
( 0%)
+6.01%+1.27%+4.74
01/26/15 SWHC Outperform NS $12.41 $16.66
( 0%)
+34.25%+1.27%+32.98
01/20/15 ELLI Outperform NS $42.50 $71.15
( 0%)
+67.41%+2.55%+64.86
01/20/15 MSCI Outperform NS $53.72 $62.21
( 0%)
+15.80%+2.55%+13.25
01/20/15 PBH Outperform NS $35.84 $46.58
( 0%)
+29.97%+2.55%+27.41
01/20/15 MHK Outperform NS $169.85 $194.10
( 0%)
+14.28%+2.55%+11.72
01/20/15 AET Outperform NS $92.44 $128.90
( 0%)
+39.45%+2.55%+36.89
01/05/15 TJX Outperform NS $67.06 $67.42
( 0%)
+0.54%+1.67%-1.12
12/29/14 CSBK Outperform NS $13.44 $14.00
( 0%)
+4.15%-0.31%+4.46
12/11/14 ON Outperform NS $9.78 $11.57
( 0%)
+18.30%+1.81%+16.49
12/11/14 AMAG Outperform NS $39.95 $70.70
( 0%)
+76.97%+1.81%+75.16
12/02/14 VNTV Outperform NS $33.44 $38.74
( 0%)
+15.85%+0.86%+14.99
12/02/14 CSC Outperform NS $62.75 $65.92
( 0%)
+5.05%+0.86%+4.19
11/24/14 GIII Outperform NS $43.14 $71.25
( 0%)
+65.15%+0.19%+64.96
11/18/14 AZO Outperform NS $567.99 $673.14
( 0%)
+18.51%+1.53%+16.98
11/18/14 XL Outperform NS $34.20 $37.97
( 0%)
+11.01%+1.53%+9.48
10/21/14 PTRY Outperform NS $24.00 $36.74
( 0%)
+53.08%+7.57%+45.51
06/20/14 AWR Outperform NS $31.48 $37.57
( 0%)
+19.33%+5.93%+13.40
03/03/14 BSP Outperform NS $8.00 $8.91
( 0%)
+11.34%+12.39%-1.05
02/11/14 JLL Outperform NS $117.57 $172.76
( 0%)
+46.95%+14.36%+32.58
12/20/13 TQQQ Outperform NS $58.69 $108.55
( 0%)
+84.94%+14.39%+70.55
12/20/13 UMDD Outperform NS $43.61 $63.79
( 0%)
+46.28%+14.39%+31.89
12/20/13 URTY Outperform NS $82.18 $104.93
( 0%)
+27.68%+14.39%+13.29
12/20/13 UPRO Outperform NS $45.57 $67.88
( 0%)
+48.97%+14.39%+34.58
08/14/13 TCX Outperform NS $2.10 $28.31
( 0%)
+1248.10%+22.71%+1225.39

Results 1 - 63 of 63  

Featured Broker Partners


Advertisement